Hanan Goldberg

Papers

Total Citations

H-Index

About

Dr. Hanan Goldberg is a leading urologic oncologist whose research focuses on optimizing surgical decision-making for renal cell carcinoma (RCC), particularly in complex cases involving T1b-T2 tumors. His major contribution lies in elucidating the nuanced trade-offs between partial nephrectomy (PN) and radical nephrectomy (RN), demonstrating how patient-specific factors—including tumor complexity and comorbidities—impact perioperative outcomes. By analyzing newly available data, Dr. Goldberg provides evidence-based guidance for surgeons navigating the debate between nephron-sparing benefits and oncologic efficacy. His work has garnered significant attention, with his most cited study accumulating 6 citations, reflecting its practical relevance to clinical practice. Dr. Goldberg’s research empowers clinicians to tailor surgical approaches to individual patient risk profiles, ultimately improving recovery and survival outcomes. His contributions are instrumental in advancing personalized care for localized RCC, making him a respected voice in urologic oncology.